Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Menley & James entering cough/cold sector with OTC version of Adams Labs' Humibid.

This article was originally published in The Tan Sheet

Executive Summary

MENLEY & JAMES TO ENTER COUGH/COLD SECTOR WITH OTC VERSION OF HUMIBID, a prescription multisymptom product manufactured and sold by Medeva PLC subsidiary Adams Labs. Menley & James announced March 20 that it will begin shipping the OTC product to trade in June; the product will be available regionally in drug stores and mass merchandisers beginning in early fall. The company is targeting nationwide availability by the start of the 1997 cold season.
Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

PS084921

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel